Salmones Camanchaca SA
SGO:SALMOCAM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 261
2 857.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CLP.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Salmones Camanchaca SA
Cash & Cash Equivalents
Salmones Camanchaca SA
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Salmones Camanchaca SA
SGO:SALMOCAM
|
Cash & Cash Equivalents
$14.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
M
|
Multiexport Foods SA
SGO:MULTIX
|
Cash & Cash Equivalents
$29.6m
|
CAGR 3-Years
66%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
E
|
Empresas Iansa SA
SGO:IANSA
|
Cash & Cash Equivalents
$24m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-5%
|
|
|
W
|
Watt's SA
SGO:WATTS
|
Cash & Cash Equivalents
clp6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
B
|
Blumar SA
SGO:BLUMAR
|
Cash & Cash Equivalents
$35.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
C
|
Carozzi SA
SGO:CAROZZI
|
Cash & Cash Equivalents
clp62.4B
|
CAGR 3-Years
41%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Salmones Camanchaca SA
Glance View
Salmones Camanchaca SA engages in fish farming. The company is headquartered in Puerto Montt, Los Lagos. The company went IPO on 2018-02-02. The firm focuses on the cultivating and processing of salmon and trout. The firm is a subsidiary of Cia Pesquera Camanchaca SA.
See Also
What is Salmones Camanchaca SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
14.6m
USD
Based on the financial report for Jun 30, 2024, Salmones Camanchaca SA's Cash & Cash Equivalents amounts to 14.6m USD.
What is Salmones Camanchaca SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
9%
Over the last year, the Cash & Cash Equivalents growth was 94%. The average annual Cash & Cash Equivalents growth rates for Salmones Camanchaca SA have been 12% over the past three years , 9% over the past five years .
You don't have any saved screeners yet